Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Artisan Partners Small Cap Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Small cap growth fund declined 7.97% in Q3 as Fed's higher-for-longer stance pressured valuations. Healthcare drove positive security selection through biotech pipeline progress, while medical devices faced GLP-1 headwinds."
Artisan Small Cap Fund declined 7.97% in Q3 2023, narrowly trailing the Russell 2000 Growth Index amid continued small cap underperformance. The quarter was dominated by macroeconomic narratives as the Fed reiterated its higher-for-longer stance, sending long-term yields soaring and pressuring growth stocks. Healthcare was the portfolio's biggest positive contributor through security selection, driven by encouraging biotech pipeline news from holdings like Argenx, which reported successful CIDP trial results. However, medical device stocks faced headwinds from GLP-1 obesity drug concerns. The manager initiated new positions in WESCO, CCC Intelligent Solutions, and Stevanato Group while exiting HubSpot, Envista, and Generac. Despite frustration with prolonged small cap underperformance, the team remains optimistic about long-term prospects, noting Russell 2000 valuations relative to large caps are at levels last seen before the dot-com bubble. The portfolio maintains focus on franchise characteristics and profit cycle acceleration, with particular interest in early-stage consumer and Internet opportunities positioned for growth acceleration.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High conviction evidenced by concentrated portfolio with named, sized positions and specific thesis explanations for each holding. Manager provides detailed rationale for position changes and demonstrates deep knowledge of individual companies. Clear Garden/Crop/Harvest framework shows systematic approach to position sizing based on conviction levels.
Growth Outlook
Manager acknowledges challenging macro environment with Fed's higher-for-longer stance and rising yields, but maintains that current interest rate levels are not surprising and similar to pre-QE periods. Shows cautious optimism about long-term small cap prospects despite near-term headwinds.
Risk Appetite
Portfolio maintains selective risk-taking through new Garden positions and adding to existing holdings like Saia and SPX Technologies. However, also harvesting positions and trimming others, indicating measured approach rather than aggressive risk-on positioning.
Capital Deployment
Modest net deployment through new Garden positions in WESCO, CCC Intelligent Solutions, and Stevanato Group, plus additions to Saia and SPX Technologies. However, this is largely offset by exits from HubSpot, Envista, and Generac, plus trims to several positions, resulting in limited net deployment activity.
Forward Guidance
Manager expresses optimism about finding early-stage opportunities in consumer and Internet sectors, and sees attractive valuations in GLP-1 impacted medical device stocks. Continues active deployment into new positions while maintaining disciplined approach to capital allocation.
Language Signal
Language is balanced with both opportunity-focused terms (attractive valuations, optimistic, encouraging results) and risk-aware language (frustration, headwinds, concerns). Slightly more constructive than bearish overall but notably measured in tone.
Perceived Risk
Manager identifies multiple specific risks including rising interest rates, macroeconomic weakness, inflation impacts on consumer spending, and various economic headwinds like potential government shutdown and auto strikes. Discusses sector-specific concerns around GLP-1 impact on medical devices and cyclical pressures.
Opportunity Density
Manager sees selective opportunities in defined areas including early-stage consumer and Internet sectors, GLP-1 impacted medical device stocks, and companies benefiting from secular tailwinds. Characterizes environment as requiring selectivity but identifies multiple specific themes and opportunities.
Time Horizon
Demonstrates multi-year investment horizon through Garden/Crop/Harvest framework designed for profit cycle development. Discusses long-term themes like energy transition, digitalization trends, and demographic shifts. Willing to hold through short-term volatility as evidenced by maintaining positions despite GLP-1 headwinds.
